CD19-directed Chimeric Antigen Receptor
DBCAT005468Therapeutic category
A DrugBank category of 2 drugs. 2 of them are approved.
What you can answer from here — as of June 02, 2021
Which targets do CD19-directed Chimeric Antigen Receptor share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account